FGF23 and X-linked dominant hypophosphatemic rickets: FGF23 levels are increased in patients with XLHR, ADHR, ARHR1, and ARHR2 leading to phosphaturia, low serum phosphate, and low serum 1,25(OH)2D3 level due to its inhibition of vitamin D 1-α hydroxylase.